CCC
MET icon

Crescent Capital Consulting’s MetLife MET Stock Holding History

Crescent Capital Consulting’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$106K Hold
1,694
– – 0.02% 226
2021
Q3 		$105K Buy
1,694
+112
+7% +$6.74K 0.02% 224
2021
Q2 		$95K Buy
1,582
+82
+5% +$5.2K 0.02% 224
2021
Q1 		$91K Hold
1,500
– – 0.02% 237
2020
Q4 		$70K Buy
+1,500
New +$65K 0.02% 223

Other funds holding MET

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Crescent Capital Consulting's MET Position: Q4 2021 in Review

Crescent Capital Consulting held its MetLife (MET) position steady in Q4 2021 at 1,694 shares worth $106K. The position accounts for 0.02% of the portfolio, ranked #226.

Crescent Capital Consulting first reported a position in MET in Q4 2020 and has held it in 5 quarters since. 1,193 funds tracked by Wall St. Rank hold MET as of Q4 2021.

  • Crescent Capital Consulting held 1,694 shares of MetLife worth $106K as of Q4 2021.
  • Crescent Capital Consulting left its MetLife share count unchanged in Q4 2021.
  • MetLife made up 0.02% of Crescent Capital Consulting's portfolio in Q4 2021, its #226 holding.
  • Crescent Capital Consulting first reported a position in MetLife in Q4 2020 and has held it in 5 quarters since.
  • 1,193 funds tracked by Wall St. Rank held MetLife as of Q4 2021.

Based on Crescent Capital Consulting's 13F filing for Q4 2021, filed 18 Jan 2022.